Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.
Start 7-day free trial → Log in

OD-07656

Other · developed by Odyssey Therapeutics

Phase 2 Most advanced trial
ODTX Developer
1 Registered trials

What is OD-07656?

OD-07656 is an investigational drug studied in Ulcerative Colitis (UC), UC - Ulcerative Colitis.

At a glance

Drug type
Other
Therapy area
Gastroenterology
Developer
Odyssey Therapeutics (ODTX)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 2

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT06850727 Phase 2 Ulcerative Colitis (UC) Recruiting ODTX

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

UC - Ulcerative ColitisUlcerative Colitis (UC)

More from Odyssey Therapeutics

PRV-002 Phase 1

Follow ODTX, the company behind OD-07656

See ODTX's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

ODTX catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.